Policy Filings and Resources

The Consumer Technology Association advocates for innovation by working with policymakers and providing feedback on a range of technology policy issues.

2024

General Advocacy | July 3, 2024
CTA CIRCIA Comment Letter
Trade | June 28, 2024
CTA Comments on the Proposed Modifications to Sec. 301 Tariffs

Comments to the Office of the U.S. Trade Representative.

Health and Fitness | June 26, 2024
CTA Telehealth Modernization Act Letter
General Advocacy | June 26, 2024
CTA Letter on American Privacy Rights Act and AM Radio for Every Vehicle Act
General Advocacy | June 5, 2024
The 2023 Merger Guidelines: A Giant Leap in the Wrong Direction
Trade | June 4, 2024
CTA Post-Hearing Comments on Promoting Supply Chain Resilience

Comments to the Office of the U.S. Trade Representative.

Trade | May 22, 2024
CTA Comments on the Sec. 301 Investigation in the Shipbuilding Sector

Comments to the Office of the U.S. Trade Representative.

General Advocacy | May 14, 2024
CTA Joins Amicus Brief Opposing FTC's Noncompete Rule
General Advocacy | May 6, 2024
CVAA Biennial Report
General Advocacy | May 06, 2024
CTA Comments on Rep. Bera Health AI RFI
Trade | May 3, 2024
CTA Oral Testimony for May 3 USTR Hearing on Promoting Supply Chain Resilience
General Advocacy | April 30, 2024
Testimony of Gary Shapiro, House Energy & Commerce Hearing on AM Radio
General Advocacy | April 30, 2024
CTA Comments to BIS on "Securing the Information and Communication Technology and Services Supply Chain: Connected Vehicles."
Trade/Vehicle Tech | April 30, 2024
CTA Comments on the Connected Vehicles ANPRM

Comments to the Bureau of Industry and Security within the Department of Commerce.

General Advocacy | April 30, 2024
CTA Comments on Impersonation Fraud Supplemental Notice

Comments to the Federal Trade Commission

General Advocacy | April 29, 2024
CTA Comments on Infrastructure as a Service (IaaS) Providers

Comments to the Department of Commerce

Connectivity | April 26, 2024
CTA Reply Comments on Unlicensed Use of the 6 GHz Band
Trade/Privacy | April 19, 2024
CTA Comments on the Data Security ANPRM

Comments to the Department of Justice.

General Advocacy | April 16, 2024
CTA Statement for the Record for Congressional Hearings on 2024 U.S. Trade Agenda
Connectivity | March 27, 2024
CTA Letter to FCC on Unlicensed Use of the 6 GHz Band

Comment Letter to Federal Communications Commission (FCC)

Digital Health | March 18, 2024
CTA Comments on Achieving 100% Hearing Aid Compatibility (HAC) Rule
General Advocacy | March 11, 2024
CTA Comments on Children’s Online Privacy Protection Rule

Comments to Federal Trade Commission (FTC)

General Advocacy | March 6, 2024
Letter to Governor Youngkin opposing Tech Tax
General Advocacy | February 23, 2024
CTA Letter Requesting to Vacate HSR Proposed Rulemaking

Letter to the Federal Trade Commission (FTC)

General Advocacy | February 21, 2024
CTA Comments to USTR on Extension of Exclusions from the Section 301 Tariffs
Artificial Intelligence | February 2, 2024
CTA Comments in Response to NIST RFI
Immigration | February 1, 2024
CTA Joins Amicus Brief to the 5th Circuit Court of Appeals in Support of the DACA Program
Accessibility | January 30, 2024
CTA Statement for the Record for House Small Business Committee Hearing
General Advocacy | January 12, 2024
CTA Report: PNTR Revocation is a Recipe for Inflation
General Advocacy | January 11, 2024
Multi-Association Letter on FCC's U.S. Cyber Trust Mark Program
General Advocacy | January 2, 2024
CTA Comments on Implementation of National Spectrum Strategy

Comments to National Telecommunications and Information Administration (NTIA) 

Online Speech | December 8, 2023
Supreme Court Amicus Brief Moody v. NetChoice v. Paxton

CTA joins amicus brief challenging laws in Florida and Texas that would limit the rights of online platforms to moderate third party content. 

General Advocacy | December 7. 2023
CTA joins coalition letter to Secretary Buttigieg urging action on autonomous vehicles
General Advocacy | November 27, 2023
CTA Letter to Energy & Commerce Committee on AI in Healthcare
General Advocacy | November 13, 2023
CTA Reply Comments on FCC IoT Cybersecurity Labeling NPRM

Comments to Federal Communications Commission (FCC)

General Advocacy | November 8, 2023
Gary Shapiro's Statement to Senate AI Forum
General Advocacy | November 8, 2023
Multi-Association Letter on FCC's U.S. Cyber Trust Mark Program

CTA-led coalition letter to the Federal Communications Commission (FCC)

General Advocacy | October 31, 2023
CTA Comments to U.S. Copyright Office Re: AI and Copyright

Comments to U.S. Copyright Office

Trade | October 26, 2023
CTA Comments in Support of Changes to FTC Recusal Process

Comments to Federal Trade Commission (FTC)

Trade | October 20, 2023
CTA Comments on FTC's Amplifier Rule

Comments to Federal Trade Commission (FTC)

General Advocacy | October 18, 2023
CTA U.S. Adult Emergency Alert Survey 2023
General Advocacy | October 16, 2023
CTA Reply Comments on ATSC 3.0 Standard Essential Patents (SEPs)

Comments to Federal Communications Commission (FCC)

Trade | October 6, 2023
CTA Reply Comments on Access to Videoconferencing

Comments to Federal Communications Commission (FCC)

General Advocacy | October 6, 2023
CTA Comments on FCC IoT Cybersecurity Labeling NPRM

Comments to Federal Communications Commission (FCC)

Privacy and Health | October 3, 2023
CTA Comments on Sen. Cassidy's Health Data Privacy RFI

CTA comments on Sen. Cassidy's request for information on health data privacy

Trade | September 27, 2023
CTA Comments to FTC/DOJ on Changes to HSR Merger Review Form

Comments to the Federal Trade Commission (FTC) and U.S. Department of Justice

General Advocacy | September 22, 2023
CTA Comments on Sen. Cassidy's Artificial Intelligence Whitepaper

CTA Comments on Sen. Bill Cassidy's whitepaper entitled Exploring Congress’ Framework for the Future of AI: The Oversight and Legislative Role of Congress Over the Integration of Artificial Intelligence in Health, Education, and Labor.

Self-Driving Vehicles | September 21, 2023
CTA Letter to Governor Newsom Urging Veto of CA AB 316
Trade | September 19, 2023
Testimony of Deena Ghazarian to Energy and Commerce Committee

Mapping America’s Supply Chains: Solutions to Unleash Innovation, Boost Economic Resilience, and Beat China

Trade | September 18, 2023
CTA Comments to FTC/DOJ on Draft Merger Guidelines

Comments to the Federal Trade Commission (FTC) and U.S. Department of Justice

Health | September 11, 2023
CTA Comments on CY 2024 Medicare Physician Fee Schedule Proposed Rule
Trade | September 6, 2023
CTA President and CEO Gary Shapiro's Letter to President Biden Re: China Tariffs
Accessibility | September 6, 2023
CTA Comments to Federal Communications Commission on Access to Videoconferencing

Comments to Federal Communications Commission (FCC)

Trade | August 11, 2023
CTA Comments on Advancing Inclusive, Worker-centered Trade Policy

Comments to the U.S. Trade Representative

Blockchain | August 11, 2023
CTA Joins Amicus Brief in Coinbase v. SEC
Privacy and Health | August 8, 2023
CTA Comments to Federal Trade Commission on Health Breach Notification Rule

Comments to Federal Trade Commission

Trade | July 10, 2023
CTA Comments on the proposed changes to Antidumping and Countervailing Duty Laws

Comments to the Department of Commerce

General Advocacy | June 27, 2023
CTA One-Pager on AM Radio Mandate
General Advocacy | June 23, 2023
CTA Comments on Negative Option Rule

Comments to Federal Trade Commission (FTC)

General Advocacy | June 21, 2023
CTA Comments on Business Practices of Cloud Computing Providers

Comments to Federal Trade Commission (FTC)

General Advocacy | June 20, 2023
CTA Comments on U.S. Patent and Trademark Office's Advanced Notice of Proposed Rulemaking

CTA response to the Patent and Trademark Office

General Advocacy | June 20, 2023
CTA Letter in Support of Direct Capital Access Act

Letter to U.S. Senate Committee on Commerce, Science, and Transportation and U.S. House Committee on Transportation and Infrastructure

General Advocacy | June 20, 2023
CTA AI Response Letter to Senators Hickenlooper and Blackburn

CTA AI Response Letter to Senators Hickenlooper and Blackburn.

General Advocacy | June 16, 2023
CTA Letter to Congress Following AM Radio Hearing on June 6, 2023

Letter to Subcommittee on Communications & Technology and House Energy & Commerce Committee Chair and Ranking Member.

Trade | June 16, 2023
CTA Comments on the proposed updates to Circular A-4, "Regulatory Analysis"

Comments to the Office of Management and Budget

General Advocacy | June 5, 2023
CTA Letter to Congress Urging Opposition to AM Radio Mandate for Autos

Letter to Subcommittee on Communications & Technology and House Energy & Commerce Committee Chair and Ranking Member.

Trade | May 9, 2023
CTA Comments on the Americas Partnership for Economic Prosperity

Comments to the Government of Canada

General Advocacy | May 4, 2023
CTA Testimony on Impersonation Fraud

Testimony to Federal Trade Commission on government and business impersonation fraud

General Advocacy | May 3, 2023
CTA Comments on Metaverse and Related Public Policy Considerations

Comments to European Commission 

Accessibility | April 24, 2023
CTA Comments on Hearing Aid Compatibility Task Force's Final Report and Recommendation

Comments to Federal Communications Commission (FCC)

Trade | April 19, 2023
CTA Comments on Non-Compete Proposed Rule

Comments to Federal Trade Commission (FTC)

General Advocacy | April 17, 2023
CTA Comments on National Spectrum Strategy

Comments to National Telecommunications and Information Administration (NTIA)

General Advocacy | April 14, 2023
CTA Letter Opposing FTC FY24 Budget Request

Letter to House Energy and Commerce Committee Chair and Ranking Member

Trade | April 5, 2023
CTA Statement for the Record for the Respective Hearings on the 2023 U.S. Trade Policy Agenda

Statement submitted to the Senate Finance and House Ways and Means Committees

Digital Health | March 31, 2023
CTA Comments on Telemedicine Prescribing of Buprenorphine

CTA submitted comments to the Drug Enforcement Agency in response to the DEA proposed rule Expansion of Induction of Buprenorphine via Telemedicine Encounter.

Digital Health | March 31, 2023
CTA Comments on Telemedicine Prescribing of Controlled Substances

CTA submitted comments to the Drug Enforcement Agency in response to the DEA proposed rule Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation.

General Advocacy | March 27, 2023
CTA Letter Opposing FTC FY24 Budget Request

Letter to House and Senate Appropriations Committees

Digital Health | March 20, 2023
CTA Comments on Senate Health, Education, Labor & Pensions Committee Request for Input on Health Care Workforce Shortages

Comments to Senate Health, Education, Labor & Pensions Committee

General Advocacy | March 13, 2023
CTA Comments on Button/Coin Cell Batteries

Comments to U.S. Consumer Product Safety Commission (CPSC)

Privacy and Security | March 6, 2023
CTA Comments on Privacy, Equity and Civil Rights

Comments to National Telecommunications and Information Administration (NTIA)

General Advocacy | February 28, 2023
Jeff Zients Appointment to Chief of Staff

Letter to White House

Digital Health | Feb. 22, 2023
CTA Health Priorities for 118th Congress

Letter to Congressional Leadership

Trade | Jan. 30, 2023
Implementation of Additional Export Controls

Letter to the U.S. Department of Commerce 

Competition | Jan. 25, 2023
National Economic Council Vacancy

CTA Coalition Letter to the White House 

Trade | Jan. 17, 2023
Four-Year Review of Actions Taken in the Section 301 Investigation

Comments to the United States Trade Representative  

Trade | March 23, 2022
CTA Letter on DOJ and FTC Merger Guidelines
Energy | Jan. 31, 2022
Energy Labeling Rule

Comments to the Federal Trade Commission 

Policy Issues

We are your advocates for innovation. Learn more about the issues we fight for on Capitol Hill.